Quick Takeaways
- GOLDMAN SACHS GROUP INC filed SCHEDULE 13G/A for 2SEVENTY BIO, INC. Common Stock, par value $0.0001 per share (TSVT).
- Disclosed ownership: 0%.
- Date of event: 30 Jun 2025.
GOLDMAN SACHS GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for 2SEVENTY BIO, INC. Common Stock, par value $0.0001 per share (TSVT)
- Filing Manager
- GOLDMAN SACHS GROUP INC
- Reporting Manager
- THE GOLDMAN SACHS GROUP, INC.
- Symbol
- TSVT
- Disclosed Ownership
- 308 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Aug 2025, 16:27:12 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GOLDMAN SACHS GROUP INC disclosed 0% ownership in 2SEVENTY BIO, INC. Common Stock, par value $0.0001 per share (TSVT) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Aug 2025, 16:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 0% | 308 | 0 | 133 | Name: Abhilasha Bareja | Attorney-in-fact | |
| GOLDMAN SACHS & CO. LLC | 0% | 308 | 0 | 133 | Name: Abhilasha Bareja | Attorney-in-fact |